Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 22

1.

Increasing prevalence of cirrhosis among U.S. adults aware or unaware of their chronic hepatitis C virus infection.

Udompap P, Mannalithara A, Heo NY, Kim D, Kim WR.

J Hepatol. 2016 May;64(5):1027-32. doi: 10.1016/j.jhep.2016.01.009. Epub 2016 Jan 22.

PMID:
26809112
2.

Interferon-Free Regimens for Chronic Hepatitis C: Barriers Due to Treatment Candidacy and Insurance Coverage.

Stepanova M, Younossi ZM.

Dig Dis Sci. 2015 Nov;60(11):3248-51. doi: 10.1007/s10620-015-3709-6. Epub 2015 May 19.

PMID:
25986525
3.

Inflammation, psychiatric symptoms, and opioid use are associated with pain and disability in patients with cirrhosis.

Rogal SS, Bielefeldt K, Wasan AD, Lotrich FE, Zickmund S, Szigethy E, DiMartini AF.

Clin Gastroenterol Hepatol. 2015 May;13(5):1009-16. doi: 10.1016/j.cgh.2014.10.029. Epub 2014 Nov 5.

4.

Estimating the true prevalence of hepatitis C in rhode island.

Kinnard EN, Taylor LE, Galárraga O, Marshall BD.

R I Med J (2013). 2014 Jul 1;97(7):19-24. Review.

5.

Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010.

Denniston MM, Jiles RB, Drobeniuc J, Klevens RM, Ward JW, McQuillan GM, Holmberg SD.

Ann Intern Med. 2014 Mar 4;160(5):293-300. doi: 10.7326/M13-1133.

6.

Racial disparities in the proportion of current, unresolved hepatitis C virus infections in the United States, 2003-2010.

Liu G, Holmberg SD, Kamili S, Xu F.

Dig Dis Sci. 2014 Aug;59(8):1950-7. doi: 10.1007/s10620-014-3059-9. Epub 2014 Feb 27.

PMID:
24573716
7.

The changing epidemiology of hepatitis C virus infection in the United States: National Health and Nutrition Examination Survey 2001 through 2010.

Ditah I, Ditah F, Devaki P, Ewelukwa O, Ditah C, Njei B, Luma HN, Charlton M.

J Hepatol. 2014 Apr;60(4):691-8. doi: 10.1016/j.jhep.2013.11.014. Epub 2013 Nov 27.

PMID:
24291324
8.

Current and future disease progression of the chronic HCV population in the United States.

Zalesak M, Francis K, Gedeon A, Gillis J, Hvidsten K, Kidder P, Li H, Martyn D, Orne L, Smith A, Kwong A.

PLoS One. 2013 May 21;8(5):e63959. doi: 10.1371/journal.pone.0063959. Print 2013.

9.

Associations of chronic hepatitis C with metabolic and cardiac outcomes.

Younossi ZM, Stepanova M, Nader F, Younossi Z, Elsheikh E.

Aliment Pharmacol Ther. 2013 Mar;37(6):647-52. doi: 10.1111/apt.12234. Epub 2013 Feb 5.

10.

African americans are less likely to have clearance of hepatitis C virus infection: the findings from recent U.S. population data.

Mir HM, Stepanova M, Afendy M, Kugelmas M, Younossi ZM.

J Clin Gastroenterol. 2012 Sep;46(8):e62-5. doi: 10.1097/MCG.0b013e318238352b.

PMID:
22178959
11.

The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings.

Rein DB, Smith BD, Wittenborn JS, Lesesne SB, Wagner LD, Roblin DW, Patel N, Ward JW, Weinbaum CM.

Ann Intern Med. 2012 Feb 21;156(4):263-70. doi: 10.7326/0003-4819-156-4-201202210-00378. Epub 2011 Nov 4.

PMID:
22056542
12.

All-cause, liver-related, and non-liver-related mortality among HCV-infected individuals in the general US population.

El-Kamary SS, Jhaveri R, Shardell MD.

Clin Infect Dis. 2011 Jul 15;53(2):150-7. doi: 10.1093/cid/cir306. Epub 2011 Jun 10.

13.

Insurance status and treatment candidacy of hepatitis C patients: analysis of population-based data from the United States.

Stepanova M, Kanwal F, El-Serag HB, Younossi ZM.

Hepatology. 2011 Mar;53(3):737-45. doi: 10.1002/hep.24131. Epub 2011 Feb 11.

PMID:
21319199
14.

Sex and age differences in lipid response to chronic infection with the hepatitis C virus in the United States National Health and Nutrition Examination Surveys.

Lao XQ, Thompson A, McHutchison JG, McCarthy JJ.

J Viral Hepat. 2011 Aug;18(8):571-9. doi: 10.1111/j.1365-2893.2010.01347.x. Epub 2010 Jul 19.

PMID:
20642483
15.

Hepatitis C virus infection, age, and Hispanic ethnicity increase mortality from liver cancer in the United States.

Younossi ZM, Stepanova M.

Clin Gastroenterol Hepatol. 2010 Aug;8(8):718-23. doi: 10.1016/j.cgh.2010.04.017. Epub 2010 May 18.

PMID:
20435163
16.

Increased caffeine consumption is associated with reduced hepatic fibrosis.

Modi AA, Feld JJ, Park Y, Kleiner DE, Everhart JE, Liang TJ, Hoofnagle JH.

Hepatology. 2010 Jan;51(1):201-9. doi: 10.1002/hep.23279.

17.

Health-related quality of life in children with hepatitis C acquired in the first year of life.

Nydegger A, Srivastava A, Wake M, Smith AL, Hardikar W.

J Gastroenterol Hepatol. 2008 Feb;23(2):226-30. doi: 10.1111/j.1440-1746.2007.04859.x.

PMID:
18289357
18.

Hepatitis C virus genotypes and viral concentrations in participants of a general population survey in the United States.

Nainan OV, Alter MJ, Kruszon-Moran D, Gao FX, Xia G, McQuillan G, Margolis HS.

Gastroenterology. 2006 Aug;131(2):478-84.

PMID:
16890602
19.
20.

Racial differences in the relationship between hepatitis C infection and iron stores.

Ioannou GN, Dominitz JA, Weiss NS, Heagerty PJ, Kowdley KV.

Hepatology. 2003 Apr;37(4):795-801.

PMID:
12668972
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk